References

Position statement on antiplatelet therapy for East Asians with coronary artery disease: 2025 update

10.1016/j.jacasi.2025.04.010 · 2025 · External reference

Twenty-year clinical experience of the Korea acute myocardial infarction registry

10.4070/kcj.2025.0360 · 2025 · External reference

Current status of acute myocardial infarction in Korea

10.3904/kjim.2018.381 · 2019 · External reference

New horizons of acute myocardial infarction: from the Korea Acute Myocardial Infarction Registry

10.3346/jkms.2013.28.2.173 · 2013 · External reference

Third-generation P2Y12 inhibitors in East Asian acute myocardial infarction patients: a nationwide prospective multicentre study

10.1055/s-0038-1626697 · 2018 · External reference

Clinical outcomes of adjusted-dose versus standard-dose prasugrel in East Asian patients with acute myocardial infarction

10.1016/j.ijcard.2024.132197 · 2024 · External reference

Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention

10.1093/ehjcvp/pvaa005 · 2021 · External reference

One-year clinical outcomes between single-versus multi-staged PCI for ST elevation myocardial infarction with multi-vessel coronary artery disease: from KAMIR-NIH

10.4070/kcj.2019.0176 · 2020 · External reference

2021 Korean Society of Myocardial Infarction expert consensus document on revascularization for acute myocardial infarction

10.4070/kcj.2021.0043 · 2021 · External reference

2024 Korean Society of myocardial Infarction/National Evidence-Based Healthcare Collaborating Agency guideline for the pharmacotherapy of acute coronary syndromes

10.4070/kcj.2024.0257 · 2024 · External reference